Skip to main content
See who owns your news
Published • loading... • Updated

Merck Still Imports 80% of Its Raw Materials, Here's Its Strategy for Dealing with Geopolitics and the Weak Rupiah

Summary by medcom.id
Around 80 percent of the raw materials for Merck's biopharma products are still imported, primarily from France, Switzerland, and Germany. |P&G's raw materials are also around 75-80 percent imported, primarily from China, so geopolitical dynamics are a concern for the company. |Merck manages exchange rate risk through hedging at the group level, intercompany transactions in rupiah, and natural hedging from export activities.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Around 80 percent of the raw materials for Merck's biopharma products are still imported, primarily from France, Switzerland, and Germany. |P&G's raw materials are also around 75-80 percent imported, primarily from China, so geopolitical dynamics are a concern for the company. |Merck manages exchange rate risk through hedging at the group level, intercompany transactions in rupiah, and natural hedging from export activities.

·Indonesia
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

medcom.id broke the news in Indonesia on Thursday, October 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal